Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoar... Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. Show more
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation PR Newswire ENGLEWOOD, Colo., April 3, 2024 ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc...
Ampio Announces Voluntary Delisting and SEC Deregistration PR Newswire ENGLEWOOD, Colo., March 25, 2024 ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE...
Ampio Provides Update on Results from Pre-IND Enabling Studies PR Newswire ENGLEWOOD, Colo., Feb. 14, 2024 ENGLEWOOD, Colo., Feb. 14, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Symbol | Price | Vol. |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | $ 26.9496 (0.00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | $ 31.69 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | $ 26.3554 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | $ 25.705 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | $ 25.065 (0.00%) | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.